Glycated hemoglobin levels and their correlation with atherosclerotic risk factors in a Japanese population - The Jichi Medical School of Cohort Study 1993-1995

Japanese Circulation Journal

Volumn 62, Issue 4, 1998, Pages 261-266

  Kayaba, Kazunori ^c,d   Nago, Naoki ^c   Miyamoto, Takeshi ^a   Mizooka, Masafumi ^b   Terada, Mitsukazu ^b   Kario, Kazuomi ^c   Nakamura, Yosikazu ^c   Igarashi, Masahiro ^c  

^a Okawa Natl Health Insurance Clinic   (Japan)

^b Sakugi Clinic   (Japan)

^c JICHI MEDICAL UNIVERSITY   (Japan)

^d Yukiguni Yamato General Hospital   (Japan)

Author keywords

Cardiovascular risk factors; Factor VII; Fibrinogen; Hemoglobin A glycosylated; Lipoprotein(a)

Indexed keywords

FIBRINOGEN; GLYCOSYLATED HEMOGLOBIN; LIPOPROTEIN A;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CHOLESTEROL BLOOD LEVEL; CORONARY RISK; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; RISK FACTOR;

EID: 0031893529     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.62.261     Document Type: Article

References (50)

1. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H: Mortality from coronary heart disease and stroke in relation to degree of glycemia: the Whitehall Study: Br Med J 1983; 287: 867-870
2. Pyörälä K, Laakso M, Uusitupa M: Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev 1987; 3: 463-524
3. McKeigue PM, Keen H: Diabetes, insulin, ethnicity, and coronary heart disease. In: Marmot M, Elliott P, editors. Coronary heart disease epidemiology. Oxford: Oxford University Press, 1992: 217-232
4. Barrett-Connor E, Wingard DL, Criqui MH, Suarez L: Is borderline fasting hyperglycemia a risk factor for cardiovascular death? J Chron Dis 1984; 37: 773-779
5. Singer DE, Nathan DM, Andeson KM, Wilson PWF, Evans JC: Association of HbA1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study. Diabetes 1992; 41: 202-208
6. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986
7. Bunn HF, Haney DM, Kamin S, Gabbay KH, Gallop PM: The biosynthesis of human hemoglobin A1c: slow glycosylation of hemoglobin in vivo. J Clin Invest 1976; 57: 1652-1659
8. Bunn HF, Gabbay KH, Gallop PM: The glycosylation of hemoglobin: relevance to diabetes mellitus. Science 1978; 200: 21-27
9. Simon D. Coignet MC, Thibult N, Senan C, Eschwege E: Comparison of glycosylated hemoglobin and fasting plasma glucose with 2-h post-load glucose in the detection of diabetes mellitus. Am J Epidemiol 1985; 122: 589-593
10. Hanson RL, Nelson RG, McCance DR, Beart JA, Charles M, Pettitt DJ, et al: Comparison of screening tests for non-insulin-dependent diabetes mellitus. Arch Intern Med 1993; 153: 2133-2140
11. Meigs JB, Nathan DM, Cupples LA, Wilson PWF, Singer DE: Tracking of glycated hemoglobin in the original cohort of the Framingham Heart Study. J Clin Epidemiol 1996; 49: 411-417
12. Jeppsson JO, Jerntorp P, Sundkvist G, Englund H, Nylund V: Measurement of hemoglobin A1c by a new liquid-chromatographic assay: methodology, clinical utility, and relation to glucose tolerance evaluated. Clin Chem 1986; 32: 1867-1872
13. Brownlee M, Cerami A, Vlassara H: Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988; 318: 1315-1321
14. Lyons TJ: Glycation and oxidation: a rote in the pathogenesis of atherosclerosis. Am J Cardiol 1993; 71: 26B-31B
15. Chisolm GM, Irwin KC, Penn MC: Lipoprotein oxidation and lipoprotein-induced cell injury in diabetes. Diabetes 1992; 41(Suppl 2): 61-66
16. Witztum JL, Mahoney EM, Branks MJ, Fisher M, Elam R, Steinberg D: Nonenzymatic glucosylation of low-density lipoprotein alters its biologic activity. Diabetes 1982; 31: 283-291
17. Jack CM: Non-enzymatic glycosylation of low-density lipoprotein. Results of an affinity chromatography method. Diabetologia 1988; 31: 126-127
18. Laakso M: Glycemic control and the risk for coronary heart disease in patients with non-insulin-dependent diabetes mellitus: the Finnish Studies. Ann Intern Med 1996; 124: 127-130
19. Nago N, Kayaba K, Hiraoka J, Matsuo H, Goto T, Kario M, et al: Lipoprotein(a) levels in the Japanese population: influence of age and sex, and relation to atherosclerotic risk factors: the Jichi Medical School Cohort Study. Am J Epidemiol 1995; 141: 815-821
20. Gotoh T, Kuroda T, Yamasawa M, Nishinaga M, Mitsuhashi T, Seino Y, et al: Correlation between lipoprotein(a) and aortic valve sclerosis assessed by echocardiography (the JMS Cardiac Echo and Cohort Study). Am J Cardiol 1995; 76: 928-932
21. Kario K, Nago N, Kayaba K, Saegusa T, Matsuo H, Goto T, et al. on behalf of the Jichi Medical School Cohort Study Group: Characteristics of the insulin resistance syndrome in a Japanese population: the Jichi Medical School Cohort Study. Arterioscler Thrumb Vasc Biol 1996; 16: 269-274
22. Little RR, Wiedmeyer H-M, England JD, Wilke AL, Rohlfing CL, Wians Jr FH, et al: Interlaboratory standardization of measurements of glycohemoglobins. Clin Chem 1992; 38: 2472-2478
23. Weykamp CW, Penders TJ, Muskiet FA, van der Slik W: Effect of calibration on dispersion of glycohemoglobin values determined by 111 laboratories using 21 methods. Clin Chem 1994; 40: 138-144
24. The Health Service Bureau of the Ministry of Health and Welfare: Report of fourth national survey of circulatory disorders 1990. Osaka, Japan: National Cardiovascular Center; September 1993 (in Japanese with English tables and abstract)
25. Iso H, Kiyama M, Naito Y, Sato S, Kitamura A, Iida M, et al: The relation of body fat distribution and body mass with hemoglobin A1c, blood pressure and blood lipids in urban Japanese men. Int J Epidemiol 1991; 20: 88-94
26. Stickland MH, Paton RC, Wales JK: Haemoglobin A1c concentrations in men and women with diabetes. Br Med J 1984; 289: 733
27. Yudkin JS, Forrest RD, Jackson CA, Ryle AJ, Davie S, Gould BJ: Unexplained variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia. Diabelologia 1990; 33: 208-215
28. Facchini FS, Hollenbeck CB, Jeppesen J, Chen YI, Reaven GM: Insulin resistance and cigarette smoking. Lancet 1992; 339: 1128-1130
29. Nilsson PM, Lind L, Pollare T, Beme C, Lithell HO: Increased level of hemoglobin A1c, but not impaired insulin sensitivity, found in hypertensive and normotensive smokers. Metabolism 1995; 44: 557-561
30. Kawakami N, Araki S, Ohtsu H, Hayashi T, Matsumoto T, Yokoyama K: Effects of mood states, smoking and urinary catecholamine excretion on hemoglobin A1c in male Japanese workers. Ind Health 1995; 33: 153-162
31. Sosenko JM, Kubrusly DB, Goldberg RB, Fournier AM, Hsia SL, Gadia MT, et al: High-density lipoprotein and glycosylated hemoglobin in nondiabetic individuals. Arch Intern Med 1986; 146: 1521-1524
32. Manson JE, Spelsberg A: Risk modification in the diabetic patient. In: Manson JE, Ridker PM, Gaziano JM, Hennekens CH, editors. Prevention of myocardial infarction. New York: Oxford University Press, 1996: 241-273
33. Stout RW: Insulin and atheroma - an update. Lancet 1987; II: 1077-1078
34. Jones RL, Peterson CM: Hematologic alterations in diabetes mellitus. Am J Med 1981; 70: 339-352
35. Prydz H: The tissue factor pathway and cardiovascular disease. In: Francis Jr RB, editor: Atherosclerotic cardiovascular disease, hemostasis, and endothelial function. New York: Marcel Dekker, 1992: 35-52
36. Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti R, North WRS, et al: Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; 2: 533-537
37. Wilhelmsen L, Svärdsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G: Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984; 311: 501-505
38. Stones MC, Thorp JM: Plasma fibrinogen - a major coronary risk factor. J R Coll Gen Pract 1985; 35: 565-569
39. Kannel WB, Wolf PA, Castelli WP, D'Agostino RB: Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA 1987; 258: 1183-1186
40. Yarnell WG, Baker IA, Sweetnam PM, Bainton D, O'Brien JR, Whitehead PJ, et al: Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease, the Caerphilly and Speedwell collaborative heart disease studies. Circulation 1991; 83: 836-844
41. Folsom AR, Wu KK, Davis CE, Conlan MG, Sorlie PD, Szklo M: Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis 1991; 91: 191-205
42. Balleisen L, Assmann G, Bailey J, Epping P-H, Schulte H, van de Loo J: Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population-II. Baseline data on the relation to blood pressure, blood glucose, uric acid, and lipid fractions. Thromb Haemost 1985; 54: 721-723
43. Kario K, Matsuo T, Kobayashi H, Matsuo M, Sakata T, Miyata T: Activation of tissue factor-induced coagulation and endothelial cell dysfunction in non-insulin-dependent diabetic patients with microalbuminuria. Arterioscler Thromb Vasc Biol 1995; 15: 1114-1120
44. Ceriello A, Giugliano D, Quatraro A, Russo PD, Torella R; Blood glucose may condition factor VII levels in diabetic and normal subjects. Diabetologia 1988; 31: 889-891
45. Wenger NK: Gender differences in coronary risk and risk factors. In: Manson JE, Ridker PM, Gaziano JM, Hennekens CH, editors. Prevention of myocardial infarction. New York: Oxford University Press, 1996: 387-412
46. Ramirez LC, Arauz-Pacheco C, Lackner C, Albright G, Adams BV, Raskin P: Lipoprotein(a) levels in diabetes mellitus: relationship to metabolic control. Ann Intern Med 1992; 117: 42-47
47. Maser RE, Drash AL, usher D, Kuller LH, Becker DJ, Orchard TJ: Lipoprotein(a) concentration shows little relationship to IDDM complications in the Pittsburgh Epidemiology of Diabetes Complications Study Cohort. Diabetes Care 1993; 16: 755-758
48. Sidhu M, Crook D, Godsland IF, Walton C, Wynn V, Oliver MF: Inverse relationship between serum Lp(a) levels and first-phase insulin secretion. Diabetes 1992; 41: 1341-1345
49. Boerwinkle E, Leffert CC, Lin J, Lackner C, Chiesa G, Hobbs HH: Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein concentrations. J Clin Invest 1992; 90: 52-60
50. Matsuo H, Watanabe S, Ohashi H: Hereditability of Lp(a) and other lipids in Japanese rural area Takasu - JMS cohort study (abstract). Jpn Circ J 1994; 58: 528